Clinical Trials for Relapsed or Refractory B Cell Non Hodgkin Lymphoma

Find clinical trials for relapsed or refractory b cell non hodgkin lymphoma. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.

NCT ID: NCT06970496

This clinical trial is testing a new treatment called B019 injection for patients with a type of cancer known as B-cell non-Hodgkin's lymphoma, specifically for those whose cancer has come back or ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Guangzhou, Guangdong, China, Xi'an, , China +5 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions